MedTrace Logo

Association of Non-alcoholic Fatty Liver Disease and Coronary Artery Disease

NCT01638832 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 572

Last updated 2012-07-12

No results posted yet for this study

Summary

This study will evaluate the association of non-alcoholic fatty liver disease and coronary artery disease. All patients presenting for coronary angiogram will receive the following examination:

* Transient Elastography and Controlled Attenuation Parameter using the FibroScan
* blood examination including biochemical markers The results of non-invasive liver steatosis and fibrosis measurement are compared with the results of coronary angiogram concerning the presence or absence of coronary artery disease.

Conditions

  • Nonalcoholic Steatohepatitis (NASH)

Interventions

DEVICE

Transient Elastography (FibroScan), Echosens, Paris, France

DEVICE

Controlled Attenuation Parameter (CAP), Echosens, Paris, France

Sponsors & Collaborators

  • Johann Wolfgang Goethe University Hospital

    lead OTHER

Principal Investigators

  • Mireen Friedrich-Rust, MD · Klinikum der J. W. Goethe-Universität Frankfurt am Main

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-06-30
Primary Completion
2013-09-30
Completion
2013-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01638832 on ClinicalTrials.gov